Upgrade to SI Premium - Free Trial

William Blair maintains Outperform rated on Cabaletta Bio Inc. (CABA) amid trial progress

March 23, 2026 4:44 PM
William Blair analyst Sami Corwin reiterated an Outperform rating on Cabaletta Bio Inc. (NASDAQ: CABA)The analyst commented, "In our view ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments